JP2009503097A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503097A5
JP2009503097A5 JP2008525163A JP2008525163A JP2009503097A5 JP 2009503097 A5 JP2009503097 A5 JP 2009503097A5 JP 2008525163 A JP2008525163 A JP 2008525163A JP 2008525163 A JP2008525163 A JP 2008525163A JP 2009503097 A5 JP2009503097 A5 JP 2009503097A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
disease
prednisolone acetate
prednisolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008525163A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009503097A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/030140 external-priority patent/WO2007019184A2/en
Publication of JP2009503097A publication Critical patent/JP2009503097A/ja
Publication of JP2009503097A5 publication Critical patent/JP2009503097A5/ja
Pending legal-status Critical Current

Links

JP2008525163A 2005-08-04 2006-08-03 酢酸プレドニゾロンの経口懸濁液 Pending JP2009503097A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70537005P 2005-08-04 2005-08-04
PCT/US2006/030140 WO2007019184A2 (en) 2005-08-04 2006-08-03 Oral suspension of prednisolone acetate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012236009A Division JP2013014634A (ja) 2005-08-04 2012-10-25 酢酸プレドニゾロンの経口懸濁液

Publications (2)

Publication Number Publication Date
JP2009503097A JP2009503097A (ja) 2009-01-29
JP2009503097A5 true JP2009503097A5 (enExample) 2009-09-17

Family

ID=37727875

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008525163A Pending JP2009503097A (ja) 2005-08-04 2006-08-03 酢酸プレドニゾロンの経口懸濁液
JP2012236009A Abandoned JP2013014634A (ja) 2005-08-04 2012-10-25 酢酸プレドニゾロンの経口懸濁液

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012236009A Abandoned JP2013014634A (ja) 2005-08-04 2012-10-25 酢酸プレドニゾロンの経口懸濁液

Country Status (11)

Country Link
US (4) US7799331B2 (enExample)
EP (2) EP1909798A4 (enExample)
JP (2) JP2009503097A (enExample)
KR (1) KR20080044245A (enExample)
CN (1) CN101247786A (enExample)
AU (1) AU2006278620B2 (enExample)
CA (1) CA2616112A1 (enExample)
IL (1) IL189257A0 (enExample)
NZ (1) NZ566117A (enExample)
WO (1) WO2007019184A2 (enExample)
ZA (1) ZA200800926B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799331B2 (en) 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007117605A2 (en) * 2006-04-06 2007-10-18 Taro Pharmaceuticals North America, Inc. Novel spill-resistant formulations comprising hydrocolloidal polymers
CN101888829A (zh) * 2007-10-09 2010-11-17 诺瓦提斯公司 缬沙坦的药物制剂
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
KR101245604B1 (ko) 2007-11-13 2013-03-21 메리테이지 파마, 인크. 코르티코스테로이드 조성물
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
LT2328553T (lt) * 2008-08-20 2020-09-10 The Regents Of The University Of California Kortikosteroidai, skirti virškinimo trakto uždegiminių ligų gydymui
WO2010144865A2 (en) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
KR20180126087A (ko) * 2016-05-06 2018-11-26 임프리미스 파마슈티컬스 인코포레이티드 약학적 안과용 조성물 및 그의 제조 방법
EP3509572A4 (en) * 2016-09-08 2020-05-13 Synergistic Therapeutics, LLC TOPICAL FORMULATION FOR HAIR GROWTH

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265823A (en) * 1979-01-04 1981-05-05 Robert E. Kosinski Aurothiosteroids
US4448774A (en) * 1982-12-22 1984-05-15 Fisons Corporation Steroid formulation
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US5525605A (en) * 1992-07-30 1996-06-11 Tokyo Tanabe Company Limited Remedy for inflammatory intestinal diseases
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
US20030203976A1 (en) * 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
US5480914A (en) 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
CA2342797A1 (en) * 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
EP1370226A2 (en) * 2001-01-24 2003-12-17 Oraceutical LLC Topical oral care compositions
KR100824491B1 (ko) 2001-10-05 2008-04-22 콤비네이토릭스, 인코포레이티드 면역염증 질환의 치료를 위한 조합
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
KR20040080439A (ko) 2001-12-12 2004-09-18 파마시아 코포레이션 에폭시-스테로이드성 알도스테론 수용체 길항제에 의한안구 질환의 치료 방법
AU2003238221A1 (en) 2002-06-17 2003-12-31 Taro Pharmaceuticals U.S.A, Inc. Ibuprofen suspension
EP1658083B1 (en) * 2003-06-19 2007-08-08 BODOR, Nicholas S. Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
CA2550811C (en) * 2003-12-24 2012-05-01 Jane Hirsh Temperature-stable formulations, and methods of development thereof
PL1744760T3 (pl) * 2004-04-22 2015-04-30 Acucort Ab Kompozycja farmaceutyczna do ostrego leczenia glikokortykosteroidami
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
US7799331B2 (en) * 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate

Similar Documents

Publication Publication Date Title
JP2009503097A5 (enExample)
ES2742525T3 (es) Composiciones de corticosteroides administradas oralmente
ES2339790T3 (es) Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
ES2658166T3 (es) Producto para administración oral
US8840924B2 (en) Compositions and methods of making rapidly dissolving ionically masked formulations
ES2462536T3 (es) Comprimido orodispersable multicapa
ES2270335T3 (es) Composicion farmaceutica de efecto rapido.
JP5841151B2 (ja) 鼻腔噴霧剤
ES3027652T3 (en) Orally inhaled and nasal benzodiazepines
KR20150011807A (ko) 자일리톨계 항-점액성 조성물과 관련 방법 및 조성물
ES2624585T3 (es) Sistema de suministro de compuesto terapéutico oral
TWI343263B (en) Patches for mucosa of oral cavity containing fentanyl
JP6049624B2 (ja) 苦味のある薬物のための経口用医薬フィルム製剤
EP4076380B1 (en) Transmucosal therapeutic system containing agomelatine
ES2744495T3 (es) Preparación farmacéutica sólida
ES2266288T3 (es) Pulverizador nasal tixotropico.
EP4076381B1 (en) Transmucosal therapeutic system containing agomelatine
ES2272689T3 (es) Dihidro-triterpenos en el tratamiento de infecciones virales, enfermedad cardiovascular, inflamacion, hipersensibilidad o dolor.
Patel et al. Mucoadhesive buccal drug delivery system.
JP2005518435A5 (enExample)
Haddadzadegan et al. Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations
JP5828007B2 (ja) 局所投与型の嚥下障害改善用医薬品
ES2507570T3 (es) Terapia de combinación de Zn/trimetoprim
EP3704123A1 (en) Hydrophobic acid addition salts and pharmaceutical formulations thereof
WO2011064769A1 (en) Methods and pharmaceutical compositions for the treatment of hot flashes